{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:31:28Z","timestamp":1791203488628,"version":"4.2.0"},"reference-count":47,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"DOI":"10.1210\/jc.2006-1909","type":"journal-article","created":{"date-parts":[[2007,8,29]],"date-time":"2007-08-29T02:34:17Z","timestamp":1188354857000},"page":"4671-4677","source":"Crossref","is-referenced-by-count":87,"title":["Effects of Atorvastatin on Bone in Postmenopausal Women with Dyslipidemia: A Double-Blind, Placebo-Controlled, Dose-Ranging Trial"],"prefix":"10.1210","volume":"92","author":[{"given":"Henry G.","family":"Bone","sequence":"first","affiliation":[{"name":"Michigan Bone and Mineral Clinic (H.G.B.), Detroit, Michigan 48236"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas P.","family":"Kiel","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center and Harvard Medical School (D.P.K.), Boston, Massachusetts 02215"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Lindsay","sequence":"additional","affiliation":[{"name":"Regional Bone Center (R.S.L.), Helen Hayes Hospital, West Haverstraw, New York 10993"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Michael","family":"Lewiecki","sequence":"additional","affiliation":[{"name":"New Mexico Clinical Research and Osteoporosis Center (E.M.L.), Albuquerque, New Mexico 87106"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Bolognese","sequence":"additional","affiliation":[{"name":"Bethesda Health Research (M.A.B.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Leary","sequence":"additional","affiliation":[{"name":"Pacific Biometrics, Inc. (E.T.L.), Seattle, Washington 98119"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing","family":"Lowe","sequence":"additional","affiliation":[{"name":"Asia Biometrics Centre (W.L.), Pfizer Global Pharmaceuticals, Pfizer Australia, West Ryde, New South Wales 2114, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"McClung","sequence":"additional","affiliation":[{"name":"Oregon Osteoporosis Center (M.R.M.), Portland, Oregon 97213"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113484560300_R1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","article-title":"Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates.","volume":"264","author":"van Beek","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019041113484560300_R2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","article-title":"Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.","volume":"96","author":"Fisher","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113484560300_R3","doi-asserted-by":"crossref","first-page":"II42","DOI":"10.1161\/01.CIR.0000129500.29229.92","article-title":"Beyond the laboratory: clinical implications for statin pleiotropy","volume":"109","author":"Halcox","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113484560300_R4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-2005-870538","article-title":"Statins modulate the levels of osteoprotegerin\/receptor activator of NF\u03baB ligand mRNA in mouse bone-cell cultures.","volume":"37","author":"Kaji","year":"2005","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113484560300_R5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/jcb.20598","article-title":"Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.","volume":"96","author":"Viereck","year":"2005","journal-title":"J Cell Biochem"},{"key":"key\n\t\t\t\t2019041113484560300_R6","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins.","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041113484560300_R7","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1074\/jbc.M606706200","article-title":"Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation.","volume":"282","author":"Ghosh-Choudhury","year":"2007","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113484560300_R8","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1172\/JCI16198","article-title":"Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro.","volume":"111","author":"Garrett","year":"2003","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113484560300_R9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1359\/jbmr.2003.18.1.88","article-title":"The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.","volume":"18","author":"Staal","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113484560300_R10","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1006\/bbrc.2000.4232","article-title":"Simvastatin promotes osteoblast differentiation and mineralization in MC3T3\u2013E1 cells.","volume":"280","author":"Maeda","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019041113484560300_R11","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/meta.2002.34706","article-title":"The effects of lovastatin on proteasome activities in highly purified rabbit 20 S proteasome preparations and mouse MC3T3\u2013E1 osteoblastic cells.","volume":"51","author":"Murray","year":"2002","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113484560300_R12","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/hq1001.097781","article-title":"Effect of statins on bone mineral density and bone histomorphometry in rodents.","volume":"21","author":"Maritz","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019041113484560300_R13","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/jcb.21259","article-title":"Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures.","volume":"101","author":"Ruiz-Gaspa","year":"2007","journal-title":"J Cell Biochem"},{"key":"key\n\t\t\t\t2019041113484560300_R14","first-page":"277","article-title":"Simvastatin did not prevent nor restore ovariectomy-induced bone loss in adult rats.","volume":"6","author":"Yao","year":"2006","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"key\n\t\t\t\t2019041113484560300_R15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archinte.164.2.146","article-title":"Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.","volume":"164","author":"Bauer","year":"2004","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113484560300_R16","first-page":"245","article-title":"Statins and bone morphogenetic proteins: new pathways in bone formation.","volume":"31","author":"Edwards","year":"2002","journal-title":"Ann Acad Med Singapore"},{"key":"key\n\t\t\t\t2019041113484560300_R17","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0140-6736(00)02400-4","article-title":"Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.","volume":"355","author":"Chan","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113484560300_R18","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1001\/jama.283.24.3211","article-title":"HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.","volume":"283","author":"Wang","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113484560300_R19","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1001\/jama.283.24.3205","article-title":"HMG-CoA reductase inhibitors and the risk of fractures.","volume":"283","author":"Meier","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113484560300_R20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/pds.984","article-title":"Statin lipid-lowering drugs and bone mineral density.","volume":"14","author":"Solomon","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t2019041113484560300_R21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/JCD:5:2:151","article-title":"Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density.","volume":"5","author":"Funkhouser","year":"2002","journal-title":"J Clin Densitom"},{"key":"key\n\t\t\t\t2019041113484560300_R22","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1359\/JBMR.040607","article-title":"HMG-CoA reductase inhibitors and the risk of vertebral fracture.","volume":"19","author":"Schoofs","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113484560300_R23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archinte.162.5.537","article-title":"Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study.","volume":"162","author":"Pasco","year":"2002","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113484560300_R24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00198-003-1568-z","article-title":"Hip fracture risk in statin users: a population-based Danish case-control study.","volume":"15","author":"Rejnmark","year":"2004","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113484560300_R25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00774-004-0496-0","article-title":"The effect of simvastatin on serum cytokine levels and bone metabolism in postmenopausal subjects: negative correlation between TNF-\u03b1 and anabolic bone parameters.","volume":"22","author":"Tikiz","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"key\n\t\t\t\t2019041113484560300_R26","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1464-5491.2004.01292.x","article-title":"HMG-CoA reductase inhibitors prevent bone loss in patients with type 2 diabetes mellitus.","volume":"21","author":"Nakashima","year":"2004","journal-title":"Diabet Med"},{"key":"key\n\t\t\t\t2019041113484560300_R27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s001980170106","article-title":"The effect of fluvastatin on parameters of bone remodeling.","volume":"12","author":"Bjarnason","year":"2001","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113484560300_R28","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1001\/archinte.165.17.2007","article-title":"Statin use and fracture risk: study of a US veterans population.","volume":"165","author":"Scranton","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113484560300_R29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-139-2-200307150-00009","article-title":"Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women\u2019s Health Initiative Observational Study.","volume":"139","author":"LaCroix","year":"2003","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113484560300_R30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s001980200070","article-title":"Relation of statin use and bone loss: a prospective population-based cohort study in early postmenopausal women.","volume":"13","author":"Sirola","year":"2002","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113484560300_R31","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1001\/jama.285.14.1850","article-title":"Use of statins and risk of fractures.","volume":"285","author":"van Staa","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113484560300_R32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/gye.17.4.329.332","article-title":"Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density.","volume":"17","author":"De Leo","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t2019041113484560300_R33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10067-004-1053-x","article-title":"Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study.","volume":"24","author":"Tikiz","year":"2005","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t2019041113484560300_R34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/ip.8.4.276","article-title":"Lipid-lowering agents and the risk of hip fracture in a Medicaid population.","volume":"8","author":"Ray","year":"2002","journal-title":"Inj Prev"},{"key":"key\n\t\t\t\t2019041113484560300_R35","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00198-004-1793-0","article-title":"Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.","volume":"16","author":"Hatzigeorgiou","year":"2005","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113484560300_R36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.metabol.2004.01.010","article-title":"Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women.","volume":"53","author":"Lupattelli","year":"2004","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113484560300_R37","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00198-005-1897-1","article-title":"Short-term reduction in bone markers with high-dose simvastatin.","volume":"16","author":"Rosenson","year":"2005","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113484560300_R38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1359\/jbmr.040209","article-title":"Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.","volume":"19","author":"Rejnmark","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113484560300_R39","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bone.2004.05.001","article-title":"The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetes.","volume":"35","author":"Braatvedt","year":"2004","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113484560300_R40","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","author":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113484560300_R41","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1210\/jc.2004-0124","article-title":"Official positions of the international society for clinical densitometry.","volume":"89","author":"Lewiecki","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113484560300_R42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/pds.1363","article-title":"Statins and fracture risk. A systematic review.","volume":"16","author":"Toh","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t2019041113484560300_R43","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0140-6736(00)02408-9","article-title":"Oral statins and increased bone-mineral density in postmenopausal women.","volume":"355","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113484560300_R44","first-page":"1137","article-title":"HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients.","volume":"85","author":"Chung","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113484560300_R45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S8756-3282(03)00034-6","article-title":"Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study.","volume":"32","author":"Montagnani","year":"2003","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113484560300_R46","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.ATV.15.5.678","article-title":"Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.","volume":"15","author":"Nawrocki","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019041113484560300_R47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0163-7258(99)00045-5","article-title":"New insights into the pharmacodynamic and pharmacokinetic properties of statins.","volume":"84","author":"Corsini","year":"1999","journal-title":"Pharmacol Ther"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/12\/4671\/9052867\/jcem4671.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T17:30:08Z","timestamp":1556818208000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/12\/4671\/2597226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-1909","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}